Melola Discovery

← Melola Discovery

Jurnal SINTA 1

JAK2 V617F Analysis in Indonesian Myeloproliferative Neoplasms Patients

Journal of Biomedicine and Translational Research · Vol. 1 No. 2 (2015) · hlm. 27–32

DOI
10.14710/jbtr.v1i2.63
ISSN
2503-2178
Terbit
2015-12-31
Penerbit
Faculty of Medicine, Universitas Diponegoro
Bahasa
eng

Abstrak

Background: Three subtypes of myeloproliferative neoplasms (MPNs): Polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) showed overlapping phenotype. There has been no specific cytogenetic marker identified in these subtypes. JAK2 V617F mutation prevalence in Caucasian MPNs was first reported as 97% in PV, 57% in ET, and 50% in PMF.Objective: This study was done to define the prevalence of JAK2 V617F mutation and to identify cytogenetic markers in MPNs.Methods: The study design was cross-sectional. Patients who were admitted to Dr. Kariadi Hospital with clinical diagnosis of MPNs were referred for bone marrow cytogenetic analysis in Telogorejo Hospital. JAK2 V617F mutation was tested for using Amplification Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR) from peripheral blood vein. Clinical data were secondary data retrieved from hospital medical records.Results: There was no cytogenetic abnormality found in all MPNs patients. The prevalence of JAK2 V617F mutation in MPNs patients was 73,68%. Mutation prevalence distribution in each subtypes were 100% in PV, 63,6% in ET and 100% in PMF. Conclusion: Chromosomal abnormality was not found using conventional cytogenetic analysis. More sensitive methods might elucidate submicroscopic chromosomal abnormalities in these patients. The prevalence of JAK2 V617F mutation was comparable with studies in Caucasian. It is recommended that JAK2 V617F testing should be incorporated in the management therapy of MPNs in Indonesia.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 111 tautan kepenulisan bersama · 22 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Diponegoro University
  • Andalas University
  • National Nuclear Energy Agency of Indonesia
  • Yarsi University
  • Dr. Kariadi Hospital
  • Tanjungpura University
  • Politeknik ATI Padang
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Tri Indah WinarniDiponegoro University10
Nurin Aisyiyah ListyasariDiponegoro University4
Iit FitrianingrumTanjungpura University2
Annastasia EdiatiDiponegoro University2
Nydia Rena Benita SihombingDiponegoro University2
Ardy SantosaDr. Kariadi Hospital2
Achmad Zulfa JuniartoDiponegoro University2
Inu MulyantoroDiponegoro University2
Agustini UtariDiponegoro University2
Rika Ampuh HadigunaAfiliasi tidak diketahui1
Nofialdi NofialdiAfiliasi tidak diketahui1
Meilizar MeilizarAfiliasi tidak diketahui1
Nofialdi NofialdiAndalas University1
Meilizar MeilizarPoliteknik ATI Padang1
Rika Ampuh HadigunaAndalas University1
Santosa SantosaAndalas University1
Budi SetiawanAfiliasi tidak diketahui1
C SuhartiAfiliasi tidak diketahui1
Mukh SyaifudinNational Nuclear Energy Agency of Indonesia1
Yanti LusiyantiNational Nuclear Energy Agency of Indonesia1
Dwi RamadhaniNational Nuclear Energy Agency of Indonesia1
Elsa GusriantiDiponegoro University1
Ani Melani MaskoenPadjadjaran University1
Bremmy LaksonoDiponegoro University1
Syarief TaufikDiponegoro University1
Nani MaharaniDiponegoro University1
Hery Djagat PurnomoDiponegoro University1
Rayvita AN MeagratiaDiponegoro University1
Ferdy Kurniawan CayamiDiponegoro University1
Udin BahrudinDiponegoro University1
Wiwik LestariDiponegoro University1
Muhammad Hussein GasemDiponegoro University1
Nur FarhanahDr. Kariadi Hospital1
Mentari AmirYarsi University1
Siti Farhanah AuliaYarsi University1
Octaviani Indrasari RanakusumaYarsi University1
Maria BelladonnaDiponegoro University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ejournal2.undip.ac.id/index.php/jbtr/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">JAK2 V617F Analysis in Indonesian Myeloproliferative Neoplasms Patients</dc:title>
	<dc:creator>Saktini, Fanti</dc:creator>
	<dc:creator>Santosa, Santosa</dc:creator>
	<dc:creator>Faradz, Sultana MH</dc:creator>
	<dc:subject xml:lang="en-US">ARMS-PCR; cytogenetic marker; JAK2 V617F; Philadelphia chromosome; PMF; PV</dc:subject>
	<dc:description xml:lang="en-US">Background : Three subtypes of myeloproliferative neoplasms (MPNs): Polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) showed overlapping phenotype. There has been no specific cytogenetic marker identified in these subtypes. JAK2 V617F mutation prevalence in Caucasian MPNs was first reported as 97% in PV, 57% in ET, and 50% in PMF.Objective: This study was done to define the prevalence of JAK2 V617F mutation and to identify cytogenetic markers in MPNs.Methods : The study design was cross-sectional. Patients who were admitted to Dr. Kariadi Hospital with clinical diagnosis of MPNs were referred for bone marrow cytogenetic analysis in Telogorejo Hospital. JAK2 V617F mutation was tested for using Amplification Refractory Mutation System Polymerase Chain Reaction (ARMS-PCR) from peripheral blood vein. Clinical data were secondary data retrieved from hospital medical records.Results :  There was no cytogenetic abnormality found in all MPNs patients. The prevalence of JAK2 V617F mutation in MPNs patients was 73,68%. Mutation prevalence distribution in each subtypes were 100% in PV, 63,6% in ET and 100% in PMF. Conclusion : Chromosomal abnormality was not found using conventional cytogenetic analysis. More sensitive methods might elucidate submicroscopic chromosomal abnormalities in these patients. The prevalence of JAK2 V617F mutation was comparable with studies in Caucasian. It is recommended that JAK2 V617F testing should be incorporated in the management therapy of MPNs in Indonesia.</dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Medicine, Universitas Diponegoro</dc:publisher>
	<dc:contributor xml:lang="en-US">RISBIN IPTEKDOK grant, Ministry of Health</dc:contributor>
	<dc:contributor xml:lang="en-US">Beasiswa Unggulan, Ministry of Education</dc:contributor>
	<dc:contributor xml:lang="en-US">Badan Pengkajian dan Penerapan (BPPT), Tangerang.</dc:contributor>
	<dc:date>2015-12-31</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/63</dc:identifier>
	<dc:identifier>10.14710/jbtr.v1i2.63</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Biomedicine and Translational Research; Vol 1, No 2 (2015): December 2015; 27-32</dc:source>
	<dc:source>2503-2178</dc:source>
	<dc:source>10.14710/jbtr.v1i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/63/139</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Journal of Biomedicine and Translational Research</dc:rights>
</oai_dc:dc>